SEARCH

SEARCH BY CITATION

References

  • Benedet, J. L., Anderson, G. H. and Matisic, J. P., A comprehensive program for cervical cancer detection and management. Amer. J. Obstet. Gynecol., 166, 12541259 (1992).
  • Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. and Shah, K. V., Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. nat. Cancer Inst., 87, 796802 (1995).
  • Campion, M. J., McCance, D. J., Cuzick, J. and Singer, A., Progressive potential of mild cervical atypia: prospective cytological, colposcopic and virological study. Lancet, ii, 237240 (1986).
  • Cancer Research Campaign, Fact sheet 13, cervical screening, Cancer Research Campaign, London (1990).
  • Cox, J. T., Lorincz, A. T., Schiffman, M. H., Sherman, M. E., Cullen, A. and Kurman, R. J., Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytological diagnosis of atypical squamous cells of undetermined significance. Amer. J. Obstet. Gynecol., 172, 946954 (1995).
  • Cuzick, J., Szarewski, A., Terry, G., Ho, L., Hanby, A., Maddox, P., Anderson, M., Kocjan, G., Steele, S. T. and Guillebaud, J., Human papillomavirus testing in primary cervical screening. Lancet, 345, 15331536 (1995).
  • Duncan, I. D. (ed.), NHS cervical screening programme. Guidelines for clinical practice and programme management, National Coordinating Network, Oxford (1992).
  • Eron, L. J. and 17 others, Interferon therapy for condyloma acuminata. New Engl. J. Med., 315, 10591064 (1986).
  • Given, F. T. and Jones, H. W., Self-Administered cervical cancer screening. Clin. Obstet. Gynecol., 35, 312 (1992).
  • Herbst, A. L., The Bethesda system for cervical/Vaginal cytological diagnoses. Clin. Obstet. Gynecol., 35, 2227 (1992).
  • Herrero, R., Brinton, L. A., Reeves, W. C., Brenes, M. M., De Britton, R. C., Gaitan, E. and Tenorio, F., Screening for cervical cancer in Latin America: a case-Control study. Int. J. Epidemiol., 21, 10501056 (1992).
  • Johnston, E., Office of population, censuses and surveys. English life tables, 14, HMSO, London (1986).
  • Jones, M. H., The emotional trauma of premalignant disease of the lower genital tract. Clin. Pract. Gynecol., 2, 273293 (1990).
  • McIndoe, W. A., McLean, M. A., Jones, R. W. and Mullins, P. R., The invasive potential of carcinoma in situ of the cervix. Obstet. Gynecol., 64, 451454 (1984).
  • Meijer, C. J. L. M., van den Brule, A. J. C., Snijders, P. J. F., Helmerhorst, T., Kenemans, P. and Walboomers, J. M. M., Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. In: N.Muñoz, F. X.Bosch, K. V.Shah and A.Meheus (eds.), The epidemiology of cervical cancer and human papillomairus, pp. 271281, IARC Scientific Publications 119, IARC, Lyon (1992).
  • Melkert, P. W. J., Hopman, E., van den Brule, A. J. C., Risse, E. J. K., van Diest, P. J., Bleker, O. P., Helmerhorst, T., Schipper, M. E. I., Meijer, C. J. L. M. and Walboomers, J. M. M., Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-Dependent. Int. J. Cancer, 53, 919923 (1993).
  • Mitchell, H. and Medley, G., Adherence to recommendations for early repeat cervical smear tests. Brit. med. J., 298, 16051607 (1989).
  • Mobius, G., Cytological early detection of cervical carcinoma: possibilities and limitations. Analysis of failures. J. Cancer Res. clin. Oncol., 119, 513521 (1993).
  • Muñoz, N. and Bosch, F. X., Epidemiology of cervical cancer. In: N.Muñoz, F. X.Bosch and O. M.Jensen (eds.), Human papillomavirus and cervical cancer, pp. 939, IARC Scientific Publications 94, IARC, Lyon (1989).
  • Muñoz, N. and Bosch, F. X., HPV and cervical neoplasia: review of case-Control and cohort studies. In: N.Muñoz, F. X.Bosch K. V.Shah and A.Meheus (eds.), The epidemiology of cervical cancer and human papillomavirus, pp. 251261, IARC Scientific Publications 119, IARC, Lyon (1992).
  • Richart, R. M. and Barron, B. A., A follow-Up study of patients with cervical dysplasia. Amer. J. Obstet. Gynecol., 105, 386393 (1969).
  • Schneider, A. and Koutsky, L. A., Natural history and epidemiological features of genital HPV infection. In: N.Muñoz, F. X.Bosch, K. V.Shah and A.Meheus (eds.), The epidemiology of cervical cancer and human papillomavirus. pp. 2552, IARC Scientific Publications 119, IARC, Lyon (1992).
  • Sherlaw-Johnson, C., Gallivan, S., Jenkins, D. and Jones, M. H., Cytological screening and management of abnormalities in prevention of cervical cancer: an overview with stochastic modelling. J. clin. Pathol., 47, 430435 (1994).
  • Smith, A., Elkind, A. and Eardley, A., Making cervical screening work. Brit. med. J., 298, 16621664 (1989).
  • Syrjänen, K. J., Human papillomavirus in genital carcinogenesis. Sex. Transm. Dis., 21 (Suppl. 2), S86S89 (1994).
  • Tidbury, P., Singer, A. and Jenkins, D., CIN 3: the role of lesion size in invasion. Brit. J. Obstet. Gynaecol., 99, 583586 (1992).
  • Wain, G. V., Farnsworth, A. and Hacker, N. F., The Papanicolaou smear histories of 237 patients with cervical cancer. Med. J. Austz., 157, 1416 (1992).
  • Woolley, P. D. and Talbot, M. D., Experience in Sheffield: follow-Up of abnormal cervical cytology. Int. J. STD AIDS, 1, 9597 (1990).